Pangali rega marang bathi TransCode Therapeutics, Inc. (RNAZ)

TransCode Therapeutics, Inc. - logo grafis emiten RNAZ

TransCode Therapeutics (RNAZ) maintains a strong position due to exclusive rights to an RNA drug delivery system for cancer and influence within government agencies, while the separate_pe metric stands at -0.60. The confirmed price history on this chart is supplemented by data regarding colossal testing costs and the complexity of scientific research. Current success is based on nanoparticles, however, long-term business sustainability depends on the final results of human trials.

Pangali P/E transcodetherapeutics.com (RNAZ): kanggo periode 04.07.2022 - 10.11.2026

Rincian metrik komprehensif lan analitis TransCode Therapeutics Inc. (RNAZ)

- rega lan prakiraan konsensus rega:
Rega saham TransCode|RNAZ - Bagan rega target
- rincian kapitalisasi pasar:
Kapitalisasi pasar TransCode Therapeutics, Inc.|RNAZ - Nilai Total Perusahaan
- statistik nilai buku emiten:
Aset Bersih saben Saham TransCode Therapeutics|RNAZ - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih transcodetherapeutics.com|RNAZ - Aset Agregat Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Modal TransCode Therapeutics|RNAZ - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal TransCode|RNAZ - Gunggung utang perusahaan|Utang-utang marang nilai buku TransCode Therapeutics, Inc.|RNAZ - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan TransCode Therapeutics|Rasio likuiditas perantara transcodetherapeutics.com
- rincian bathi lan kelipatan pasar:
RNAZ - Bathi resik|Penghasilan resik sing dikarepake TransCode Therapeutics|RNAZ - Pangali P/E|Rasio prakiraan rega marang bathi TransCode|RNAZ - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan TransCode Therapeutics, Inc.|RNAZ - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) TransCode Therapeutics|RNAZ - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan transcodetherapeutics.com|RNAZ - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep TransCode Therapeutics
Ringkesan analisis perusahaan:RNAZ (transcodetherapeutics.com)
Produk asli transcodetherapeutics.com

TransCode Therapeutics (RNAZ) focuses on innovative RNA therapy methods for oncological diseases. The ratio of market capitalization to net income determines the cost of one dollar of the issuer's current earnings. Investors use this coefficient to assess whether an asset is overbought relative to its actual income. In the absence of commercial revenue and given high R&D costs, this metric often becomes negative. By analyzing the fundamental P/E of TransCode Therapeutics (RNAZ), one can evaluate the degree of speculation in current quotes.

Perusahaan pesaing

Pangali P/E Tempus AI Inc|Rasio rega marang bathi Qiagen (QGEN)|Ionis Pharmaceuticals, Inc. - Pangali rega marang bathi|Rasio rega marang bathi Repligen Corp. RGEN|Periode bali modal bisnis Avidity Corp (RNA)|CRISPR Therapeutics AG - Pangali P/E|genedx.com (WGS) - Koefisien rega marang bathi|Ultragenyx (RARE) - Rasio rega marang bathi|Kapitalisasi marang bathi Beam Therapeutics Inc (BEAM)|SRPT (Sarepta Therapeutics Inc) - Pangali P/E|Pangali rega marang bathi TWST (Twist Bioscience Corp)|Pangali P/E TXG|NTLA - Kapitalisasi marang bathi|Stoke Therapeutics, Inc. - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik BLFS|WVE: Koefisien rega marang bathi|Maze Therapeutics Corp - Rasio rega pasar marang bathi resik|SION: Pangali P/E|primemedicine.com - Nilai perusahaan marang bathi resik|TSHA (Taysha Gene Therapies, Inc.) - Pangali P/E|Kapitalisasi marang bathi uniQure NV QURE|Rasio rega marang bathi MeiraGTx PLC (MGTX)|RGNX (REGENXBIO Corp) - Nilai perusahaan marang bathi resik|Pangali P/E SLDB (Solid Biosciences Inc.)|Pangali P/E ocugen.com OCGN|PACB - Rasio rega marang bathi|Kapitalisasi marang bathi resik BNTC|DSGN: Pangali P/E|Kapitalisasi marang bathi Rocket Corp (RCKT)|Koefisien rega marang bathi FDMT|Pangali P/E Lexeo|Koefisien rega marang bathi KRRO (Korro Bio, Inc.)|Rasio rega pasar marang bathi resik EDIT|Pangali P/E SLN (Silence Therapeutics Inc.)|Periode bali modal bisnis ProQR (PRQR)|Codexis Bio - Pangali P/E|sangamo.com (SGMO) - Koefisien rega marang bathi|nautilus.bio (NAUT) - Rasio rega marang bathi|MGX - Periode bali modal bisnis|Rasio rega marang bathi Precision BioSciences, Inc.|GBIO: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Boundless Bio, Inc. (BOLD)|exicuretx.com - Pangali rega marang bathi|Pangali P/E IMNN (Imunon)|Pangali P/E Phio Pharmaceuticals Corp PHIO|MBIO: Koefisien rega marang bathi|Kapitalisasi marang bathi resik BNGO|APDN: Pangali P/E|Pangali rega marang bathi BLUE|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd|Pangali rega marang bathi OMGA (Omega Therapeutics Inc)|Pangali P/E OMIC|Pangali P/E Regulus (RGLS)|Syros Pharmaceuticals - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik TBIO (telesisbio.com)|TCON - Rasio rega marang bathi|Nilai perusahaan marang bathi resik UBX (Unity Biotechnology Inc.)